Sugammadex allows fast-track bariatric surgery

Obesity Surgery

Volumn 23, Issue 10, 2013, Pages 1558-1563

  Carron, Michele ^a   Veronese, Stefano ^a   Foletto, Mirto ^a   Ori, Carlo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Adjustable gastric banding; Fast track surgery; Morbidly obese patient; Neuromuscular blockade; Sugammadex

Indexed keywords

ATROPINE; DESFLURANE; DEXAMETHASONE; FENTANYL; KETOPROFEN; MIDAZOLAM; NARCOTIC AGENT; NEOSTIGMINE; ONDANSETRON; OXYGEN; PROPOFOL; RANITIDINE; REMIFENTANIL; ROCURONIUM; SUGAMMADEX;

ADULT; ANESTHETIC RECOVERY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GASTRIC BANDING; HUMAN; MALE; MORBID OBESITY; NEUROMUSCULAR BLOCKING; OPERATION DURATION; OXYGEN SATURATION; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SWALLOWING;

ADULT; ANESTHESIA RECOVERY PERIOD; BARIATRIC SURGERY; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR JUNCTION; OBESITY, MORBID; PARASYMPATHOMIMETICS; TREATMENT OUTCOME;

EID: 84884669361     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-0926-y     Document Type: Article

References (35)

1. Raeder J. Bariatric procedures as day/short stay surgery: is it possible and reasonable? Curr Opin Anaesthesiol. 2007;20(6):508-12.
2. Servin F. Ambulatory anesthesia for the obese patient. Curr Opin Anaesthesiol. 2006;19(6):597-9.
3. Murphy GS, Szokol JW, Marymont JH, et al. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107(1):130-7.
4. Butterly A, Bittner EA, George E, et al. Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge. Br J Anaesth. 2010;105(3):304-9.
5. Jones RK, Caldwell JE, Brull SJ, et al. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology. 2008;109(5):816-24.
6. Gaszynski T, Szewczyk T, Gaszynski W. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia. Br J Anaesth. 2012;108(2):236-9.
7. Carron M, Guzzinati S, Ori C. Simplified estimation of ideal and lean body weights in morbidly obese patients. Br J Anaesth. 2012;109(5):829-30.
8. Bartkowski RR. Incomplete reversal of pancuronium neuromuscular blockade by neostigmine, pyridostigmine, and edrophonium. Anesth Analg. 1987;66(7):594-8.
9. Kopman AF. Neostigmine versus sugammadex: which, when, and how much? Anesthesiology. 2010;113(5):1010-1.
10. Suzuki T, Masaki G, Ogawa S. Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients. Br J Anaesth. 2006;97(2):160-3.
11. Leykin Y, Miotto L, Pellis T. Pharmacokinetic considerations in the obese. Best Pract Res Clin Anaesthesiol. 2011;25(1):27-36.
12. Debaene B, Plaud B, Dilly MP, et al. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003;98(5):1042-8.
13. Carron M, Parotto E, Ori C. Prolonged neuromuscular block associated to non-alcoholic steatohepatitis in morbidly obese patient: neostigmine versus sugammadex. Minerva Anestesiol. 2012;78(1):112-3.
14. Vanacker BF, Vermeyen KM, Struys MM, et al. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth Analg. 2007;104(3):563-8.
15. Duvaldestin P, Kuizenga K, Saldien V, et al. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia. Anesth Analg. 2010;110(1):74-82.
16. Eikermann M, Gerwig M, Hasselmann C, et al. Impaired neuromuscular transmission after recovery of the train-of-four ratio. Acta Anaesthesiol Scand. 2007;51(2):226-34.
17. Igarashi A, Amagasa S, Horikawa H, et al. Vecuronium directly inhibits hypoxic neurotransmission of the rat carotid body. Anesth Analg. 2002;94(1):117-22.
18. Eikermann M, Vogt FM, Herbstreit F, et al. The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade. Am J Respir Crit Care Med. 2007;175(1):9-15.
19. Eriksson LI, Sundman E, Olsson R, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology. 1997;87(5):1035-43.
20. Carron M, Freo U, Ori C. Sugammadex for treatment of postoperative residual curarization in a morbidly obese patient. Can J Anaesth. 2012;59(8):813-4.
21. Suzuki T, Fukano N, Kitajima O, et al. Normalization of acceleromyographic train-of-four ratio by baseline value for detecting residual neuromuscular block. Br J Anaesth. 2006;96(1):44-7.
22. Plaud B, Debaene B, Donati F, et al. Residual paralysis after emergence from anesthesia. Anesthesiology. 2010;112(4):1013-22.
23. Carron M, Parotto E, Ori C. The use of sugammadex in obese patients. Can J Anaesth. 2012;59(3):321-2.
24. Freo U, Carron M, Innocente F, et al. Effects of A-line Autoregression Index (AAI) monitoring on recovery after sevoflurane anesthesia for bariatric surgery. Obes Surg. 2011;21(7):850-7.
25. Juvin P, Vadam C, Malek L, et al. Postoperative recovery after desflurane, propofol, or isoflurane anesthesia among morbidly obese patients: a prospective, randomized study. Anesth Analg. 2000;91(3):714-9.
26. Strum EM, Szenohradszki J, Kaufman WA, et al. Emergence and recovery characteristics of desflurane versus sevoflurane in morbidly obese adult surgical patients: a prospective, randomized study. Anesth Analg. 2004;99(6):1848-53.
27. La Colla L, Albertin A, La Colla G, et al. Faster wash-out and recovery for desflurane vs sevoflurane in morbidly obese patients when no premedication is used. Br J Anaesth. 2007;99(3):353-8.
28. McKay RE, Malhotra A, Cakmakkaya OS, et al. Effect of increased body mass index and anaesthetic duration on recovery of protective airway reflexes after sevoflurane vs desflurane. Br J Anaesth. 2010;104(2):175-82.
29. Bailey JM. Context-sensitive half-times and other decrement times of inhaled anesthetics. Anesth Analg. 1997;85(3):681-6.
30. Paul M, Fokt RM, Kindler CH, et al. Characterization of the interactions between volatile anesthetics and neuromuscular blockers at the muscle nicotinic acetylcholine receptor. Anesth Analg. 2002;95(2):362-7.
31. Douglas WW, Kehlet H. Management of patients in fast track surgery. BMJ. 2001;322(7284):473-6.
32. Chung SA, Yuan H, Chung F. A systemic review of obstructive sleep apnea and its implications for anesthesiologists. Anesth Analg. 2008;107(5):1543-63.
33. Gan TJ, Meyer T, Apfel CC, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg. 2003;97(1):62-71.
34. Paraskeva A, Papilas K, Fassoulaki A, et al. Physostigmine does not antagonize sevoflurane anesthesia assessed by bispectral index or enhances recovery. Anesth Analg. 2002;94(3):569-72.
35. Løvstad RZ, Thagaard KS, Berner NS, et al. Neostigmine 50 microg kg(-1) with glycopyrrolate increases postoperative nausea in women after laparoscopic gynaecological surgery. Acta Anaesthesiol Scand. 2001;45(4):495-500.